“Beyond UniQure, the pipeline includes highly promising approaches that will ideally move the goal from merely managing ...
Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of ...
After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...
But in late September, a preliminary report for a gene therapy treatment funded by UniQure showed serious promise of stopping ...
UniQure's therapy, called AMT-130, reduced disease progression by 75% at 36 months in patients who received a high dose.
Huntington’s disease is a neurological (brain) condition that causes involuntary movement, changes to emotions, behavior, and thinking. Huntington’s is a genetic disease that worsens over time.
Treatment with pridopidine slowed clinical progression and maintained function, cognition, and motor performance in pre-defined analyses of a subgroup of early-stage Huntington’s disease (HD) patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback